CONTIPRO GROUP, S.R.O. – Trademark Portfolio
Entity Type: 03
CONTIPRO GROUP, S.R.O. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 7 (Machinery) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include HYSILK, CELLCON, HYACTIVE, and RECELLINE. The owner is based in DOLNI DOBROUC.
DOLNI DOBROUC 401 CZ-561 02
DOLNI DOBROUC , CZ
Showing of trademarks Trademarks
Trademark Classifications
CONTIPRO GROUP, S.R.O.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Machines and machine tools; motors and engines; machine coupling and transmission components
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CONTIPRO GROUP, S.R.O. have?
CONTIPRO GROUP, S.R.O. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 cancelled.
What trademark classes does CONTIPRO GROUP, S.R.O. file in?
CONTIPRO GROUP, S.R.O. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 7 (Machinery), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are CONTIPRO GROUP, S.R.O.'s most well-known trademarks?
CONTIPRO GROUP, S.R.O.'s registered trademark portfolio includes well-known marks such as HYSILK, CELLCON, HYACTIVE, and RECELLINE. These are among 4 currently registered trademarks in the portfolio.
What is CONTIPRO GROUP, S.R.O.'s trademark registration success rate?
CONTIPRO GROUP, S.R.O. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.